Histological grade in breast cancer:: association with clinical and biological features in a series of 229 patients

被引:17
作者
Ruibal, A
Arias, JI
Del Río, MC
Lapeña, G
Schneider, J
Tejerina, A
机构
[1] Fdn Jimenez Diaz, Nucl Med Serv, E-28040 Madrid, Spain
[2] Tejerina Fdn, Madrid, Spain
[3] Monte Naranco Hosp, Dept Gen Surg, Oviedo, Spain
[4] Alfonso X el Sabio Univ, Sch Med, Madrid, Spain
[5] Ctr Breast Dis, Madrid, Spain
关键词
histological grade; breast carcinomas; tumor size; proliferation; hyaluronic acid;
D O I
10.1177/172460080101600108
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In order to study the association of histological grade (HC) with specific clinical and biological parameters which may influence the clinical behavior of infiltrating ductal carcinomas of the breast (IDC), we analyzed in 229 tissue samples the cytosolic concentrations of estrogen receptor (ER), progesterone receptor (PR), pS2, cathepsin D, hyaluronic acid (HA) and tissue-type plasminogen activator (t-PA), as well as those of the erbB2 oncoprotein, epidermal growth factor receptor (EGFR), HA, CD44v5 and CD44v6 in the cell membrane fraction. Likewise, we considered size, ploidy, S-phase fraction and axillary node involvement as variables of the study. The transition from HG1 to HG2 and from HG2 to HG3 was accompanied by a number of common features: global increase in size, greater number of tumors >2.0 cm, decrease in membrane hyaluronic acid concentrations, increased cell proliferation (S-phase >7%) and greater aneuploidy. Other events observed during the transition from HG2 to HG3 were a decrease in ER, PR, t-PA and cytosolic hyaluronic acid. These results led us to consider that HG is associated with certain clinical-biological changes that may help explain its value as a prognostic factor in breast carcinomas.
引用
收藏
页码:56 / 61
页数:6
相关论文
共 53 条
[1]  
Auvinen PK, 1997, INT J CANCER, V74, P477, DOI 10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.0.CO
[2]  
2-0
[3]  
BARBI GP, 1994, ONCOLOGY, V51, P329
[4]   HYALURONAN (HYALURONIC-ACID) AND HYALURONECTIN IN THE EXTRACELLULAR-MATRIX OF HUMAN BREAST CARCINOMAS - COMPARISON BETWEEN INVASIVE AND NONINVASIVE AREAS [J].
BERTRAND, P ;
GIRARD, N ;
DELPECH, B ;
DUVAL, C ;
DANJOU, J ;
DAUCE, JP .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (01) :1-6
[5]   The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen [J].
Billgren, AM ;
Rutqvist, LE ;
Johansson, H ;
Hägerström, T ;
Skoog, L .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1374-1380
[6]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[7]   Specific oncological contribution of cathepsin D and pS2 in human breast cancer: Their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification [J].
Bolufer, P ;
Torregrosa, MD ;
Gomez, L ;
Munarriz, B ;
Lopez, JA ;
Asins, E ;
Espinoza, S ;
Vera, F ;
Vazquez, C ;
Guillem, V .
CLINICA CHIMICA ACTA, 1996, 247 (1-2) :89-103
[8]  
CHEVALLIER B, 1988, B CANCER, V75, P23
[9]   PREDICTION OF RELAPSE OR SURVIVAL IN PATIENTS WITH NODE-NEGATIVE BREAST-CANCER BY DNA FLOW-CYTOMETRY [J].
CLARK, GM ;
DRESSLER, LG ;
OWENS, MA ;
POUNDS, G ;
OLDAKER, T ;
MCGUIRE, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (10) :627-633
[10]   Clinical course and prognostic factors following bone recurrence from breast cancer [J].
Coleman, RE ;
Smith, P ;
Rubens, RD .
BRITISH JOURNAL OF CANCER, 1998, 77 (02) :336-340